Diversa, IntraBiotics, Syngenta Seeds AG deal

DVSA and IBPI will develop antibacterials and antifungals by screening DVSA’s PathwayLibraries recombinant natural product libraries for antimicrobial activity. IBPI will have an exclusive worldwide license to any products developed, and DVSA will receive technology access fees, research support, and milestone and royalty payments. ...